Novadaq Technologies Inc.  

(Public, NASDAQ:NVDQ)   Watch this stock  
Find more results for NVDQ
9.12
-0.19 (-2.04%)
Feb 10 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.00 - 9.50
52 week 9.00 - 17.29
Open 9.31
Vol / Avg. 0.00/428,831.00
Mkt cap 523.72M
P/E     -
Div/yield     -
EPS -0.74
Shares 56.25M
Beta 1.11
Inst. own     -
Feb 23, 2016
Novadaq Technologies Inc at RBC Capital Markets Healthcare Conference - 11:30AM EST - Add to calendar
Feb 17, 2016
Q4 2015 Novadaq Technologies Inc Earnings Call - 4:30PM EST - Add to calendar
Feb 17, 2016
Q4 2015 Novadaq Technologies Inc Earnings Release - 4:00PM EST - Add to calendar
Jan 12, 2016
Novadaq Technologies Inc at JPMorgan Healthcare Conference (Q&A)
Jan 12, 2016
Novadaq Technologies Inc at JPMorgan Healthcare Conference - Webcast
Dec 2, 2015
Novadaq Technologies Inc at Piper Jaffray Healthcare Conference - Webcast
Nov 19, 2015
Novadaq Technologies Inc at Canaccord Genuity Medical Technology & Diagnostics Forum
Nov 18, 2015
Novadaq Technologies Inc at Stifel Healthcare Conference
Nov 16, 2015
Novadaq Technologies Inc Analyst & Investor Day
More events from DailyFinance »    

Address

5090 Explorer Dr Suite 202
MISSISSAUGA, ON L4W 4T9
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Novadaq Technologies Inc. develops and commercializes medical imaging and therapeutic devices for use in the operating room. The Company's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. The Company generates revenues from the sale of medical devices and consumables, capital devices or consumable products, the rental of capital devices, royalties, upfront payments received from partners for exclusive sales and marketing rights, and extended warranty services agreements in connection with capital sales. The Company’s SPY imaging products are SPY Elite, FIREFLY, LUNA, PINPOINT, CO2 HEART LASER systems and DermACELL Advanced Decellularized Dermis. The SPY Imaging System is United States Food and Drug Administration (FDA) cleared for use in seven surgical specialties, including coronary artery bypass, cardiovascular, plastic, reconstructive, micro, organ transplant and gastrointestinal surgery.

Officers and directors

Arun Menawat Ph.D. President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Roger Deck Chief Financial Officer
Bio & Compensation  - Reuters
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Bio & Compensation  - Reuters
Patrice E. Merrin Director
Age: 66
Bio & Compensation  - Reuters
Robert S. White Director
Bio & Compensation  - Reuters
Aaron Davidson Independent Director
Age: 46
Bio & Compensation  - Reuters
Harold O. Koch Jr. Independent Director
Age: 59
Bio & Compensation  - Reuters